AMLN Update
We've been following AMLN all day.AMLN's CEO just appeared on CNBC and spoke about the heavy strength the company's shares are experiencing today.
Do you sell into the strength or hold on?
Hold, we say.
AMLN is 2 for 2 this year.
The pop today, CNBC says, is a result of hedge funds getting short squeezed.
As to why hedge funds would short AMLN (AMLN stock fell during the last 6 months) I have no idea.
This is a boutique biotech who has partnered up with several larger players, including Eli Lilly (LLY).
We're issuing a Hold recommendation.
<< Home